United Kingdom


UK increases access to cannabis-based medicines as import restrictions are changed

Import restrictions have been changed to help ensure people with prescriptions for cannabis-based products for medicinal use do not have their treatment delayed or interrupted.

The changes will help patients with conditions such as rare, serious forms of epilepsy or multiple sclerosis.

Most cannabis-based medicines are imported from foreign countries. Export restrictions mean it can take weeks or months for the drugs to reach the patients in the UK. For example, in Canada, an export certificate can take 4 to 8 weeks.


Canadian company Sundial to grow U.K. CBD after buying supermarket supplier

Following a C$250 million boost, Canadian firm Sundial Growers has splashed out one of the U.K’s largest horticultural operations to supply the booming European CBD market.


UK food safety company partners cannabis producer

The Glasgow-based company produces test kits that test foodstuffs such as milk, spices, cereals and animal feed for toxins, including mycotoxins, microorganisms and GMOs. Recently developed methods have been applied to plant products such as herbal medicines, which have structural similarities to cannabis.

Claire Milligan, product manager at R-Biopharm Rhône, said: "Just like any other ingestible item, strict consumer protection legislation requires that cannabis products, including oils, cookies and cannabis plants themselves, should be tested for the presence of dangerous toxins.


U.K. legalizing cannabis supported by near-majority of voters

Almost half of Britons support the legalization of cannabis, according to a survey commissioned by a group associated with the ruling Conservative Party.


Tilray imports medical cannabis oil in bulk to UK

Tilray has managed to successfully import its first bulk supply of medical cannabis oil into the UK.


Canadian cannabis companies tapping U.K.'s deep-pocketed family offices for investment

Over the past three years, while Canadian licensed producers were raising millions in investor dollars from boutique investment firms on Bay Street, Scott Boyes embarked on a different route in the hunt for capital, one that led him to family offices and high net worth investors parked in the U.K.

“Bay Street — the Canaccords and Echelons and GMPs — were funding Canadian licensed producers that weren’t going to have any revenue or earnings for years. My U.K. partners said, ‘Look, we’ll get this funded, just come over to London,’” said Boyes, the chief executive of MPX International, which has cannabis cultivation and retail assets in Europe and South Africa and is listed on the CSE.


Tilray imports medical cannabis to U.K. after barriers are lifted

Tilray Inc. (TLRY.O) has imported its first bulk supply of medical cannabis oil into the U.K., after controversy over the confiscation of one of the Canadian company’s products led to an easing of restrictions.

The oral solution, containing both the psychoactive THC and non-intoxicating CBD compounds, is used to treat pain, chemotherapy-induced nausea and vomiting and multiple sclerosis-associated spasticity. It has already been supplied in bulk to Germany, Croatia, Cyprus and Malta.


Aurora Cannabis ships first commercial export to U.K. under new rules

Aurora Cannabis Inc. reports it has completed its first commercial export of cannabis oil to the United Kingdom and the product has been successfully dispensed from a pharmacy. “Authorities there recently granted the company approval for its first shipment of medical cannabis into the U.K. from Canada under its new legal framework that came into effect on Nov. 1, 2018,” notes a press release from Edmonton-headquartered Aurora, which has a funded capacity in excess of 500,000 kg a year and sales and operations in 22 countries across five continents.


Canada's Canopy aims to bring pot products to U.K. this year

Canopy Growth Corp. (WEED.TO 0.61%) has joined forces with a U.K. researcher of cannabis-based therapies after the British government moved to liberalize the use of medical marijuana.

The new company, formed with Beckley Canopy Therapeutics Ltd., aims to make products available in Britain from early this year. The government made it legal for specialist doctors to prescribe medical marijuana for patients with severe clinical need in November.

The decision came after studies showed that it could benefit children with conditions such as severe epilepsy, although the government said it was not a step toward legalizing cannabis for recreational use.


Subscribe to RSS - United Kingdom